This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medical Properties Trust Announces Pricing Of €200 Million Of 5.75% Senior Notes By Its Operating Partnership And MPT Finance Corporation

Medical Properties Trust, Inc. (the “Company”) (NYSE: MPW) announced today that the previously announced public offering of €200 million aggregate principal amount of senior notes due 2020 (the “Notes”) by its operating partnership, MPT Operating Partnership, L.P., a Delaware limited partnership (the “Operating Partnership”), and MPT Finance Corporation, a Delaware corporation and wholly-owned subsidiary of the Operating Partnership (“MPT Finance,” and together with the Operating Partnership, the “Issuers”), priced today with a coupon of 5.75%. The Notes will be senior unsecured obligations of the Issuers, guaranteed by the Company and by certain subsidiaries of the Operating Partnership.

The Operating Partnership intends to use the net proceeds from the offering of Notes to finance its previously announced acquisition of 11 post acute facilities in Germany from RHM Klinik-und Altenheimbetriebe GmbH & Co. KG (the “Acquisition”). The Operating Partnership intends to use any remaining net proceeds for general corporate purposes. The proceeds of the offering will be placed in escrow pending the completion of the Acquisition. If the conditions to closing the Acquisition are not satisfied or waived on or prior to 90 days after the closing of the offering of Notes, the Issuers will be required to redeem the Notes.

BofA Merrill Lynch, Deutsche Bank Securities Inc. and J.P. Morgan Securities Plc are acting as joint book-running managers, and Banco Bilbao Vizcaya Argentaria, S.A. and RBC Europe Limited are acting as lead managers for the offering of Notes.

The offering of the Notes is expected to close on or about October 10, 2013, subject to certain closing conditions. The offering of the Notes was made under an effective shelf registration statement of the Company, the Issuers and certain subsidiaries of the Operating Partnership as guarantors and a related preliminary prospectus supplement and free writing prospectus. The Company intends to file a final prospectus supplement with the Securities and Exchange Commission for the offering of the Notes to which this communication relates. When available, the final prospectus supplement may be obtained from BofA Merrill Lynch, 2 King Edward Street, EC1A 1HQ London or from Deutsche Bank Securities Inc., Attn: Prospectus Group, 60 Wall Street, New York, NY 10005-2836 or from J.P. Morgan Securities LLC, 383 Madison Avenue, 3rd Floor, New York, NY 10179, Attn: Syndicate or by visiting the EDGAR database on the Securities and Exchange Commission's web site at

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company or any of its subsidiaries, nor shall there be any sale of such securities in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The offering of Notes may be made only by means of a prospectus, which has or will be filed with the Securities and Exchange Commission.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a Birmingham, Alabama based self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. These facilities include inpatient rehabilitation hospitals, long-term acute care hospitals, regional acute care hospitals, ambulatory surgery centers and other single-discipline healthcare facilities.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,796.42 -2.07 -0.01%
S&P 500 2,086.88 -3.23 -0.15%
NASDAQ 5,106.5520 -20.9730 -0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs